Almost a decade ago, the FDA approved daratumumab (Darzalex), a groundbreaking monoclonal antibody for multiple myeloma (MM). This marked a significant shift in the MM treatment landscape, ushering in an era of immunotherapies. Experts at the 2024 International Myeloma Society (IMS) Annual Meeting highlighted the evolution of these treatments, including bispecific and monoclonal antibodies, and […]
Tag Archives: personalized medicine
Moderna, Inc. recently announced significant advancements in its mRNA medicine portfolio, spanning respiratory diseases, latent viruses, oncology, and rare diseases. This article provides a comprehensive overview of these updates, highlighting key clinical trial results and future development plans, offering valuable insights from both a pharmacist and physician perspective. Respiratory Disease Franchise: A Focus on Prevention […]